Product NDC: | 0029-6575 |
Proprietary Name: | TIMENTIN |
Non Proprietary Name: | ticarcillin disodium and clavulanate potassium |
Active Ingredient(s): | 1; 30 mg/mL; mg/mL & nbsp; ticarcillin disodium and clavulanate potassium |
Administration Route(s): | INTRAVENOUS |
Dosage Form(s): | INJECTION, SOLUTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0029-6575 |
Labeler Name: | GlaxoSmithKline LLC |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA050658 |
Marketing Category: | NDA |
Start Marketing Date: | 19901022 |
Package NDC: | 0029-6575-31 |
Package Description: | 100 mL in 1 CONTAINER (0029-6575-31) |
NDC Code | 0029-6575-31 |
Proprietary Name | TIMENTIN |
Package Description | 100 mL in 1 CONTAINER (0029-6575-31) |
Product NDC | 0029-6575 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | ticarcillin disodium and clavulanate potassium |
Dosage Form Name | INJECTION, SOLUTION |
Route Name | INTRAVENOUS |
Start Marketing Date | 19901022 |
Marketing Category Name | NDA |
Labeler Name | GlaxoSmithKline LLC |
Substance Name | CLAVULANATE POTASSIUM; TICARCILLIN DISODIUM |
Strength Number | 1; 30 |
Strength Unit | mg/mL; mg/mL |
Pharmaceutical Classes | Penicillin-class Antibacterial [EPC],Penicillins [Chemical/Ingredient],beta Lactamase Inhibitor [EPC],beta Lactamase Inhibitors [MoA] |